Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Hospira, Inc.    HSP

Financials ($)
Sales 2015 4 704 M
EBIT 2015 872 M
Net income 2015 -
Debt 2015 748 M
Yield 2015 -
Sales 2016 4 990 M
EBIT 2016 948 M
Net income 2016 687 M
Debt 2016 475 M
Yield 2016 -
P/E ratio 2015 29,40
P/E ratio 2016 25,70
EV / Sales 2015 3,47x
EV / Sales 2016 3,21x
Capitalization 15 555 M
More Financials
Hospira, Inc. is a pharmaceutical and medication drug delivery company, which engages in providing injectable drugs and infusion technologies.Its portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products.The company... 
02/10Earnings Release
More about the company
Surperformance© ratings of Hospira, Inc.
Trading Rating : - Investor Rating :
More Ratings
Latest news on HOSPIRA, INC.
09/08 ARRAY BIOPHARMA : cfo steps down, replacement named. (BRIEF)
09/05 HOSPIRA : A $90 million payday for Hospira CEO after sale to Pfizer
09/03 PFIZER : completes acquisition of injectable drugmaker Hospira
09/03 HOSPIRA : Termination of a Material Definitive Agreement, Completion of Acquisit..
09/02 HOSPIRA : and Cerner Expand Agreement to Advance Integration of I.V.-EMR Technol..
09/02 PFIZER : Receives Clearance from U.S. Federal Trade Commission for Hospira Acqui..
09/02 HOSPIRA : Announces First Installation of Plum 360 Infusion System With Hospira ..
09/01 S&P 500 Plans to Add Activision Blizzard, United Continental Holdings
More news
Sector news : Generic Pharmaceuticals
07:36a HIKMA PHARMACEUTICALS : Xellia Pharma Acquires Manufacturing Facilities from Hik..
07:18a NORFOLK SOUTHERN : Train derailment leaks soil from roche remediation
05:50a DR REDDY LABORATORIES : . Reddy's Lab plunges 6.6% on USFA warning letter
More sector news : Generic Pharmaceuticals
4-Traders Strategies on HOSPIRA, INC. 
2013End of the technical recovery
More Strategies
News from SeekingAlpha
09/08 PREMARKET BIOTECH DIGEST : Trouble For Anticoagulants, Gilead U.S. Hep C Sales
09/07 Hospira Acquisition To Add Shareholder Value For Pfizer
08/27 Activision Blizzard, United Continental set to join S&P 500
08/27 Hospira, Perkins merger to close around September 3
08/25 PREMARKET BIOTECH DIGEST : SA Author On Valeant, Stocks Tumble, Novartis Promact..

Technical analysis trends HOSPIRA, INC.
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions